Unravelling AURKB as a potential therapeutic target in pulmonary arterial hypertension using integrated transcriptomic analysis and pre-clinical studies
RNA-seq (gene expression) · human · 31 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 31 samples: 8 conditions, mostly with about 4 replicates eachGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Unraveling AURKB as a potential therapeutic target in pulmonary hypertension using integrated transcriptomic analysis and pre-clinical studiesCell reports. Medicine · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE263226_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1096310 and SRA study SRP499783. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 31 samples.
How we read this: 8 replicated groups read from 31 sample titles; they account for 31 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8188109 PAH_PASMC_Barasertib_1 PAH_PASMC_Barasertib
- GSM8188110 PAH_PASMC_Barasertib_2 PAH_PASMC_Barasertib
- GSM8188111 PAH_PASMC_Barasertib_3 PAH_PASMC_Barasertib
- GSM8188112 PAH_PASMC_Barasertib_4 PAH_PASMC_Barasertib
- GSM8188113 PAH_PASMC_siAURKB_1 PAH_PASMC_siAURKB
- GSM8188114 PAH_PASMC_siAURKB_2 PAH_PASMC_siAURKB
- GSM8188115 PAH_PASMC_siAURKB_3 PAH_PASMC_siAURKB
- GSM8188116 PAH_PASMC_siAURKB_4 PAH_PASMC_siAURKB
- GSM8188117 PAH_PASMC_siSCR_1 PAH_PASMC_siSC
- GSM8188118 PAH_PASMC_siSCR_2 PAH_PASMC_siSC
- GSM8188119 PAH_PASMC_siSCR_3 PAH_PASMC_siSC
- GSM8188120 PAH_PASMC_siSCR_4 PAH_PASMC_siSC
- GSM8188121 PAH_PASMC_Veh_1 PAH_PASMC_Veh
- GSM8188122 PAH_PASMC_Veh_2 PAH_PASMC_Veh
- GSM8188123 PAH_PASMC_Veh_3 PAH_PASMC_Veh
- GSM8188124 PAH_PASMC_Veh_4 PAH_PASMC_Veh
- GSM8188125 PAH_PASMC_siFOXM1_1 PAH_PASMC_siFOXM1
- GSM8188126 PAH_PASMC_siFOXM1_2 PAH_PASMC_siFOXM1
- GSM8188127 PAH_PASMC_siFOXM1_3 PAH_PASMC_siFOXM1
- GSM8188128 PAH_PASMC_siSCRAM_1 PAH_PASMC_siSCRAM
- GSM8188129 PAH_PASMC_siSCRAM_2 PAH_PASMC_siSCRAM
- GSM8188130 PAH_PASMC_siSCRAM_3 PAH_PASMC_siSCRAM
- GSM8188131 CTRL_PASMC_1 CTRL_PASMC
- GSM8188132 CTRL_PASMC_2 CTRL_PASMC
- GSM8188133 CTRL_PASMC_3 CTRL_PASMC
- GSM8188134 CTRL_PASMC_4 CTRL_PASMC
- GSM8188135 PAH_PASMC_1 PAH_PASMC
- GSM8188136 PAH_PASMC_2 PAH_PASMC
- GSM8188137 PAH_PASMC_3 PAH_PASMC
- GSM8188138 PAH_PASMC_4 PAH_PASMC
- GSM8188139 PAH_PASMC_5 PAH_PASMC
- GSE277556 Exploring Integrin α5β1 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension: Insights from Comprehensive Multicenter Preclinical Studies 20 samples shares hypertension, therapeutic, potential, pulmonary
- GSE21284 A critical role of microRNAs in human pulmonary arterial hypertension. miR-204: a novel therapeutic target 8 samples shares hypertension, therapeutic, pulmonary
- GSE254617 Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension. 148 samples shares hypertension, pulmonary
- GSE325715 Gene expression in patients with pulmonary hypertension due to valve heart disease 146 samples shares hypertension, pulmonary
- GSE249697 Transcriptional changes of the extracellular matrix in chronic thromboembolic pulmonary hypertension governs right ventricle remodeling and recovery 135 samples shares hypertension, pulmonary
- GSE249696 Transcriptional changes of the extracellular matrix in chronic thromboembolic pulmonary hypertension governs right ventricle remodeling and recovery [ext395_rnaseq] 95 samples shares hypertension, pulmonary
- GSE305464 Pre-clinical proof-of-concept of anti-fibrotic activity of caveolin-1 scaffolding domain peptide LTI-03 in ex vivo precision cut lung slices from patients with Idiopathic Pulmonary Fibrosis 94 samples shares pre-clinical, pulmonary
- GSE303084 Pressure Points: Endothelial Responses to Hemodynamic Stress in Health and Pulmonary Arterial Hypertension 72 samples shares hypertension, pulmonary
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.